Patients with bronchiectasis in China have a high disease burden and a low rate of use of evidence-based treatments.

The FDA has granted priority review to brensocatib to treat patients with non-cystic fibrosis bronchiectasis, according to a ...

Almost 200 species of NTM are known to us, some of which can lead to diseases such as bronchiectasis ... and/or other relevant specialists. Prior chest imaging (most importantly, prior chest CT scans ...

BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...